Difference between revisions of "Roux-en-Y gastric bypass"
Jump to navigation
Jump to search
| Line 26: | Line 26: | ||
</pre> | </pre> | ||
===IELs present=== | |||
<pre> | |||
Small Bowel, Excision during Gastric Bypass: | |||
- Small bowel wall with increased intraepithelial lymphocytes, otherwise within normal limits, see comment. | |||
Comment: | |||
The increased intraepithelial lymphocytes are likely explained by obesity; however, other causes (such as infection, inflammatory bowel disease and celiac disease) should be considered within the clinical context. | |||
</pre> | |||
==See also== | ==See also== | ||
*[[Small bowel]]. | *[[Small bowel]]. | ||
Latest revision as of 15:12, 28 November 2019
Roux-en-Y gastric bypass is procedure used to treat obesity.
General
- Treatment for obesity.
- Mortality ~0.15%.[1]
- A segment of small bowel is excised as part of the procedure.
Microscopic
Features:
- Normal small bowel wall.
Note:
- May have increased intraepithelial lymphocytes.[2]
Sign out
Small Bowel, Excision During Gastric Bypass:
- Small bowel wall within normal limits.
Small Bowel, Excision during Roux-en-Y Gastric Bypass: - Small bowel wall within normal limits.
IELs present
Small Bowel, Excision during Gastric Bypass: - Small bowel wall with increased intraepithelial lymphocytes, otherwise within normal limits, see comment. Comment: The increased intraepithelial lymphocytes are likely explained by obesity; however, other causes (such as infection, inflammatory bowel disease and celiac disease) should be considered within the clinical context.
See also
References
- ↑ Benotti, P.; Wood, GC.; Winegar, DA.; Petrick, AT.; Still, CD.; Argyropoulos, G.; Gerhard, GS. (Jan 2014). "Risk factors associated with mortality after Roux-en-Y gastric bypass surgery.". Ann Surg 259 (1): 123-30. doi:10.1097/SLA.0b013e31828a0ee4. PMID 23470583.
- ↑ Harpaz, N.; Levi, GS.; Yurovitsky, A.; Kini, S. (Mar 2007). "Intraepithelial lymphocytosis in architecturally normal small intestinal mucosa: association with morbid obesity.". Arch Pathol Lab Med 131 (3): 344; author reply 344. doi:10.1043/1543-2165(2007)131[344b:IR]2.0.CO;2. PMID 17516730.